-
Highly myopic macular holes
Friday, February 1, 2019High closure rates achieved using autologous platelet-rich plasma
-
Vitrectomy in PDR
Friday, February 1, 2019Improved techniques and equipment are driving earlier vitrectomy in proliferative diabetic retinopathy. Dermot McGrath reports
-
Understanding intermediate AMD
Friday, December 7, 2018MACUSTAR study looking for useful endpoints for intermediate AMD
-
IOLs can improve vision in AMD
Friday, December 7, 2018Hyperaspheric IOL provides good results in patients with maculopathy
-
Insights into diabetic retinopathy
Friday, December 7, 2018The 2018 Kreissig Lecture looked at the role of inflammation in the disease
-
Ophthalmologica
Friday, December 7, 2018SD-OCT improves clinical judgment in AMD Spectral domain optical coherence tomography (SD-OCT) can enhance clinical decision-making in the management of neovascular age-related macular degeneration (AMD) prospective observational clinical study. It showed that in residents with three-to-four years’ experience and specialists with more than five years’ experience, SD-OCT helped guide both groups’ recommendations for further treatment […]
-
Mistaken uveitis diagnosis
Wednesday, November 28, 2018A highly malignant but rare form of lymphoma can be mistakenly diagnosed as uveitis, representing a major diagnostic and therapeutic challenge
-
Peter Barry Memorial Lecture
Friday, November 16, 2018Paul Rosen delivered the 2018 Peter Barry Memorial Lecture at the Royal Victoria Eye and Ear Hospital, Dublin
-
Screening for DR must be extended
Thursday, November 1, 2018Detection and treatment of diabetic retinopathy has improved but battle not yet over
-
Gene therapy for LHON
Thursday, November 1, 2018Despite some unexpected but very promising results in late-stage clinical studies, researchers remain optimistic about the therapeutic potential for a novel gene therapy candidate for the treatment of Leber hereditary optic neuropathy (LHON). José-Alain Sahel MD presented an update on clinical trials with rAAV2/2-ND4 (GS010, GenSight Biologics), a gene therapy that targets LHON. He presented […]
